| Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations S Greenland, SJ Senn, KJ Rothman, JB Carlin, C Poole, SN Goodman, ... European journal of epidemiology 31 (4), 337-350, 2016 | 3190 | 2016 |
| A 4-year trial of tiotropium in chronic obstructive pulmonary disease DP Tashkin, B Celli, S Senn, D Burkhart, S Kesten, S Menjoge, ... New England Journal of Medicine 359 (15), 1543-1554, 2008 | 3053 | 2008 |
| The AB/BA design with normal data S Senn Cross-Over Trials in Clinical Research.” Chichester, West Sussex, England …, 1993 | 1695* | 1993 |
| Cross-over trials in clinical research S Senn Wiley, 2002 | 1681 | 2002 |
| Cross-over trials in clinical research S SENN Recherche 67, 02, 1992 | 1681* | 1992 |
| Statistical issues in drug development S Senn Wiley-Interscience, 2007 | 954 | 2007 |
| Statistical Issues in Drug Development Wiley: Chichester S Senn | 954* | 1997 |
| Testing for baseline balance in clinical trials S Senn Statistics in medicine 13 (17), 1715-1726, 1994 | 529 | 1994 |
| Guidelines for the content of statistical analysis plans in clinical trials C Gamble, A Krishan, D Stocken, S Lewis, E Juszczak, C Doré, ... Jama 318 (23), 2337-2343, 2017 | 470 | 2017 |
| Change from baseline and analysis of covariance revisited S Senn Statistics in medicine 25 (24), 4334-4344, 2006 | 387 | 2006 |
| Covariate imbalance and random allocation in clinical trials SJ Senn Statistics in medicine 8 (4), 467-475, 1989 | 317 | 1989 |
| Individual response to exercise training-a statistical perspective A Hecksteden, J Kraushaar, F Scharhag-Rosenberger, D Theisen, ... Journal of applied physiology 118 (12), 1450-1459, 2015 | 313 | 2015 |
| A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations JP Barrett, KA Vardulaki, C Conlon, J Cooke, P Daza-Ramirez, ... Clinical therapeutics 25 (5), 1295-1320, 2003 | 235 | 2003 |
| The relation between treatment benefit and underlying risk in meta-analysis SJ Sharp, SG Thompson, DG Altman Bmj 313 (7059), 735-738, 1996 | 220 | 1996 |
| Introduction to population pharmacokinetic/pharmacodynamic analysis with nonlinear mixed effects models JS Owen, J Fiedler-Kelly John Wiley & Sons, 2014 | 208 | 2014 |
| Surveillance of antimicrobial resistance—what, how and whither? R Bax, R Bywater, G Cornaglia, H Goossens, P Hunter, V Isham, V Jarlier, ... Clinical microbiology and infection 7 (6), 316-325, 2001 | 202 | 2001 |
| Overstating the evidence–double counting in meta-analysis and related problems S Senn BMC medical research methodology 9 (1), 10, 2009 | 201 | 2009 |
| Some controversies in planning and analysing multi‐centre trials S Senn Statistics in Medicine 17 (15‐16), 1753-1765, 1998 | 199 | 1998 |
| Mastering variation: variance components and personalised medicine S Senn Statistics in medicine 35 (7), 966-977, 2016 | 195 | 2016 |
| Seven myths of randomisation in clinical trials S Senn Statistics in medicine 32 (9), 1439-1450, 2013 | 188 | 2013 |
Sander GreenlandEmeritus Professor of Epidemiology & Statistics, UCLAVerified email at g.ucla.edu
